ADINOLFI, Luigi Elio
 Distribuzione geografica
Continente #
EU - Europa 23.384
NA - Nord America 10.317
AS - Asia 8.000
SA - Sud America 1.548
AF - Africa 103
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 6
Totale 43.380
Nazione #
RU - Federazione Russa 14.677
US - Stati Uniti d'America 10.175
SG - Singapore 3.094
IE - Irlanda 2.681
CN - Cina 1.834
HK - Hong Kong 1.480
UA - Ucraina 1.410
BR - Brasile 1.339
GB - Regno Unito 1.106
IT - Italia 1.083
DE - Germania 938
SE - Svezia 432
FI - Finlandia 392
VN - Vietnam 360
TR - Turchia 354
KR - Corea 269
GR - Grecia 231
FR - Francia 230
IN - India 195
JP - Giappone 155
AR - Argentina 78
CA - Canada 67
MX - Messico 48
ID - Indonesia 38
EC - Ecuador 37
BD - Bangladesh 36
AT - Austria 33
BE - Belgio 32
IQ - Iraq 32
NL - Olanda 32
ZA - Sudafrica 31
MA - Marocco 23
CO - Colombia 22
EU - Europa 20
RO - Romania 20
IR - Iran 19
PL - Polonia 19
PY - Paraguay 18
CZ - Repubblica Ceca 17
UZ - Uzbekistan 17
CL - Cile 14
PK - Pakistan 14
EG - Egitto 12
UY - Uruguay 12
VE - Venezuela 12
ES - Italia 11
IL - Israele 10
PE - Perù 10
MY - Malesia 9
AE - Emirati Arabi Uniti 7
LT - Lituania 7
NP - Nepal 7
SA - Arabia Saudita 7
TW - Taiwan 7
BG - Bulgaria 6
DZ - Algeria 6
KE - Kenya 6
AU - Australia 5
AZ - Azerbaigian 5
BO - Bolivia 5
ET - Etiopia 5
GE - Georgia 5
KZ - Kazakistan 5
LB - Libano 5
OM - Oman 5
PA - Panama 5
PS - Palestinian Territory 5
TN - Tunisia 5
CR - Costa Rica 4
JO - Giordania 4
SC - Seychelles 4
AL - Albania 3
AM - Armenia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
HN - Honduras 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
NO - Norvegia 3
PH - Filippine 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
HR - Croazia 2
LI - Liechtenstein 2
MD - Moldavia 2
MK - Macedonia 2
SY - Repubblica araba siriana 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
AN - Antille olandesi 1
BB - Barbados 1
BM - Bermuda 1
BW - Botswana 1
BY - Bielorussia 1
Totale 43.364
Città #
Moscow 5.027
Dublin 2.675
Jacksonville 2.125
Santa Clara 1.674
Hong Kong 1.480
Chandler 1.305
Singapore 1.110
Princeton 417
Roxbury 311
Bremen 297
Ashburn 285
Seoul 265
Medford 252
Ann Arbor 218
Boardman 215
New York 214
Beijing 206
Wilmington 193
Hefei 189
The Dalles 186
Woodbridge 186
Cambridge 182
Ho Chi Minh City 129
Bengaluru 128
Dallas 128
San Mateo 124
Nanjing 108
Düsseldorf 102
São Paulo 97
Munich 95
Caserta 94
Des Moines 82
Jinan 74
Mountain View 73
Naples 69
Hanoi 65
Napoli 65
Shenyang 57
Los Angeles 41
Norwalk 41
Nanchang 40
Tianjin 38
Helsinki 37
Rio de Janeiro 36
Zhengzhou 35
Guangzhou 34
Venice 33
Brussels 31
Changsha 31
Nuremberg 30
Shanghai 29
Milan 28
Belo Horizonte 27
Brasília 27
Hangzhou 25
Turku 25
Washington 24
Haikou 23
Houston 23
Campinas 21
Kunming 20
Toronto 20
Haiphong 19
Ningbo 19
Auburn Hills 18
Hebei 18
Da Nang 17
Salvador 17
Taizhou 17
Curitiba 16
Marano Di Napoli 16
Porto Alegre 16
Falkenstein 15
Lanzhou 15
Tokyo 15
Amsterdam 14
Baghdad 14
Bologna 14
Frankfurt am Main 14
London 14
Palermo 14
Tashkent 14
Guarulhos 13
Istanbul 13
Johannesburg 13
Redwood City 13
Taiyuan 13
Warsaw 13
Goiânia 12
Guayaquil 12
Rome 12
Seattle 12
Thái Nguyên 12
Volta Redonda 12
Atlanta 11
Brooklyn 11
Chicago 11
Dearborn 11
Jiaxing 11
Mauá 11
Totale 21.753
Nome #
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 193
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 191
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 188
Bioelectrical impedance analysisfor the assessment of body composition in patients with systemic sclerosis 185
Clinical efficacy of dirithromycin versus miocamycin in tonsillopharyngitis 178
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 177
Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study 177
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 175
A genic and epigenetic combination therapy for liver cancer 175
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 173
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 172
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 170
Sviluppo di un questionario autocompilato per la valutazione delle opinioni dei familiari sulle cause e le conseguenze psicosociali della schizofrenia (QOF) 169
Endocardite da Gemella morbillorum: descrizione di due casi 169
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 162
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 160
Activity of aminoglycosides against phagocytosed bacteria 160
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 160
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 157
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 157
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 155
Antimicrobici e sistema immune dell'ospite: bioattività intrafagocitica di antibiotici beta-lattamici 153
Chronic HCV infection and neurological and psychiatric disorders: an overview. 152
Crioglobulinemia mista essenziale associata a cirrosi epatica: aspetti clinici e terapeutici.Esperienza su una casistica clinica 151
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 150
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 149
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 148
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 148
Sonoporation by microbubbles as gene therapy approach against liver cancer 148
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 147
Circulating MiRNA-195-5p and -451a in Diabetic Patients with Transient and Acute Ischemic Stroke in the Emergency Department 146
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 145
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 144
Acute rhabdomiolisys in healthy woman. 144
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 143
All-oral interferon-free treatments: The end of hepatitis C virus story, the dream and the reality 143
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 142
Circulating miRNA-195-5p and -451a in Patients with Acute Hemorrhagic Stroke in Emergency Department 141
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 141
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 141
[Enterococcal endocarditis: clinical and microbiological features of our series] 140
An in-vitro study of treatment of drug-induced cholestasis by tauroursodeoxycholate (TUDC). 139
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 139
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 139
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 139
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 135
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 135
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 134
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 134
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 134
Antimicrobials and biological activities of immune system 133
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 132
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 132
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 132
[Effect of levamisole on changes in the of hepatic RES induced by chronic ethanol poisoning] 131
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 131
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 130
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 130
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 129
Antibiotici 129
Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci 128
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 127
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 126
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 126
Antimicrobials and biological activities of immune system. Relazione al " Bologna,pag. 3-10. 126
Comparison of dual HBV-HCV versus single HBV or HCV infections in a previous oncologic pediatric population. 125
Chronic Hepatitis C Virus Infection and Depression. 125
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 124
Predictors of early and late hepatocellular carcinoma recurrence 123
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 123
Virological patterns of HCV patients with failure to interferon-free regimens. 123
Liver's functional alterations produced from erythromycin estolate in the isolated and perfused rat liver 122
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 122
Severe Hyponatremia in the elderly: the seasonalvariability in the emergency department 122
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 122
HCV-related steatosis and risk of atherosclerosis 121
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 120
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 120
Autonomic nervous system dysfunction correlates with microvascular damage in systemic sclerosis patients 120
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 119
effetto di concentrazioni subinibenti ed effetto intrafagocitico di aztreonam, cefamandolo e netilmicina 119
Infective endocarditis due to high-level gentamicin and glycopeptides resistant enterococci: efficacy of the ampicillin-fluoroquinolones combination 119
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 118
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 118
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 118
Le infezioni cardiovascolari severe:patogeni emergenti e problematiche terapeutiche 118
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B. 118
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 117
Uncommon immune-mediated extrahepatic manifestations of HCV infection 117
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 116
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 116
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee 116
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 116
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 116
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 115
Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin 115
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 115
Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. 115
antibiotici 115
EFFICACIA DEL TRATTAMENTO CON INTERFERONE RICOMBINANTE E LINFOBLASTOIDE IN PAZIENTI CON EPATITE CRONICA DA HCV 115
Totale 13.852
Categoria #
all - tutte 149.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.655 0 0 0 0 0 34 429 357 16 414 307 98
2021/20222.572 144 9 32 60 879 22 29 67 110 220 212 788
2022/20235.182 462 88 63 392 679 405 17 334 2.492 43 103 104
2023/20241.971 149 69 76 174 718 241 23 63 8 22 131 297
2024/20256.167 26 76 86 130 989 944 801 498 787 1.031 466 333
2025/202619.842 758 862 1.128 1.231 1.956 13.907 0 0 0 0 0 0
Totale 43.974